FibroGenesis

Feb 17, 2021

FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using "Universal Acting" Fibroblast Based Immunotherapy

Oct 01, 2020

FibroGenesis Expands Fight Against COVID-19 In Brazil with International Collaboration

Sep 28, 2020

FibroGenesis Announces Manufacturing Agreement with iBiologics

Jul 01, 2020

FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation

May 21, 2020

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

Apr 21, 2020

FibroGenesis Announces the Filing of its 200th Patent for Fibroblast Cell Therapy Platform

Apr 01, 2020

FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS

Mar 10, 2020

FibroGenesis Files Patent Using its Fibroblast Cell Therapy for Coronavirus (COVID-19) ARDS